Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Targeted Patient Education Improves Outcomes - Stephen Page, SmarterHealth.AI

Targeted patient education powered by AI can reduce preventable readmissions and improve health equity, but healthcare organizations must prioritize clinical oversight, data security, and ethical governance when implementing these solutions.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · Patient EducationHealthcare AiReadmission PreventionHealth Equity
Share

Key takeaways

01

Preventable readmissions occur when patients misunderstand medications, miss symptom recognition, or lack clarity on follow-up instructions, creating clinical, operational and financial burdens for healthcare systems

02

AI-delivered patient education must meet three criteria: solve a meaningful clinical or financial problem, integrate naturally into care workflows, and avoid adding burden to patients or clinicians

03

Healthcare leaders evaluating AI tools should prioritize solutions that improve patient understanding, support clinicians, reduce avoidable utilization, protect data security, and demonstrate measurable clinical or financial results

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

AI Has the Brain, but Healthcare Still Needs the Heart

My conversation with Stephen Page explores how better patient education can improve outcomes, reduce readmissions and help healthcare organizations use artificial intelligence more responsibly.

Healthcare has never suffered from a lack of information. If anything, patients and clinicians are surrounded by more information than they can reasonably absorb, evaluate or use. The real challenge is making sure people receive information that is accurate, relevant and understandable at the moment they need it most.

That challenge was at the heart of my recent conversation with Stephen Page, founder and CEO of SmarterHealth.AI, on I Don’t Care with Dr. Kevin Stevenson.

During my years as a hospital executive, I saw how difficult effective patient education could be. Hospitals provided discharge instructions, educational materials and access to online resources, but handing someone information was never the same as helping that person understand what to do next. A patient learning about a new diagnosis, medication or procedure may be frightened, distracted or overwhelmed, which makes it difficult to retain everything explained during a clinical encounter.

A simple search for a condition such as atrial fibrillation can produce millions of results, leaving the patient to decide which sources are reliable and which information actually applies to his or her situation.

Stephen believes artificial intelligence can help address that problem by connecting patients with professionally curated information that is easier to understand, available when questions arise and adaptable to different languages and levels of health literacy.

The opportunity is not simply to give patients more content. It is to help them become better informed participants in their own care while extending education beyond the limited time available during a physician visit or hospital stay.

Patient education as more than a patient-experience initiative

Stephen and I also discussed why patient education must be viewed as more than a patient-experience initiative. Hospital executives are operating under enormous financial pressure, so any new technology must solve a meaningful clinical, operational or financial problem. Preventable readmissions provide a clear example of how those priorities intersect.

A patient can undergo a successful procedure and still return to the hospital because medications were misunderstood, symptoms were not recognized or follow-up instructions were unclear. The patient experiences another disruption in care, clinicians face additional demands and the hospital may incur a substantial financial penalty. If better education and continued engagement can prevent even a portion of those readmissions, the value reaches far beyond satisfaction scores by improving outcomes and producing a measurable financial return.

That is the standard healthcare leaders should apply when evaluating AI. An interesting concept is not enough. The technology must address an important problem, fit naturally into the care process and demonstrate that it can improve results without creating another burden for patients or clinicians.

AI’s potential to improve health equity

Our conversation also explored AI’s potential to improve health equity. Patients living in rural and underserved communities often have less access to specialists, reliable educational resources and ongoing clinical support. A platform capable of delivering credible healthcare information in numerous languages could help narrow some of those gaps, particularly when it provides patients with understandable guidance outside the walls of a hospital or physician’s office.

However, the same technology that expands access also creates serious questions about privacy, security and ethics. Stephen described being offered an AI “personal doctor” that requested extensive access to his medical records during the registration process. The potential convenience was obvious, but so was the risk. Patients deserve to know who controls their information, how it will be used and whether it could someday influence decisions involving insurance coverage, employment or other aspects of their lives.

As I told Stephen, AI may have the brain, but it does not necessarily have the heart or ethical judgment required to make every healthcare decision. That does not mean we should resist the technology. It means healthcare organizations must approach it with discipline and ensure that governance, security and clinical oversight are part of the strategy from the beginning.

Embracing AI in healthcare

Some healthcare leaders have enthusiastically embraced AI, while others are trying to keep their distance. Avoidance is no longer a viable strategy because payers, vendors and competitors are already using it. Hospitals of every size need leaders who understand what AI can do, where it can create risk and how proposed solutions should be evaluated. Even small and rural hospitals are forming committees to establish standards and determine where AI can provide meaningful value.

The organizations that benefit most will not necessarily be the ones that purchase the greatest number of AI products. They will be the ones that ask whether a solution improves patient understanding, supports clinicians, reduces avoidable utilization, protects sensitive information and produces measurable clinical or financial results.

Stephen’s message to healthcare leaders was straightforward: AI is coming, and we must learn how to embrace and leverage it effectively.

I would take that thought one step further. AI is not merely coming; it is already reshaping healthcare. Our responsibility is to ensure that it makes care more informed, accessible and human rather than simply more automated.

Consider this question: Where could better patient education make the greatest difference in your organization—in outcomes, readmissions, access or trust?

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Get  checked out

Get checked out

Seeking medical evaluation immediately after a vehicle crash, regardless of how you feel, is essential because adrenaline can mask serious injuries for hours or even up to a full day. A same-day medical visit creates a documented paper trail tied to the accident date, which protects against insurance companies disputing injury claims and denying compensation.

  • 01Feeling fine immediately after a vehicle crash may not accurately reflect one's health condition.
  • 02The body's response to stress can delay the onset of injury symptoms.
  • 03Seek medical evaluation after a crash, even if injuries aren't immediately apparent.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

Kevin Stevenson
Kevin Stevenson

Top Hospital Administrator & Healthcare COO

I Don't Care

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512